Artificial intelligence is fundamentally altering the workplace, shifting from a perceived threat to a collaborative tool that changes how employees approach productivity and job security. Recent research from the National …
study
-
-
Adults taking glucagon-like peptide-1 (GLP-1) receptor agonists for weight management report improvements in professional and social outcomes, according to recent survey data. A study published in the journal PLOS ONE …
-
Ultra-Processed Foods Linked to Cognitive Decline in Young Adults, Study Finds Young adults consuming more than 20% of daily calories from ultra-processed foods showed significantly worse memory performance, according to …
-
Regeneron’s Maftivimab, Mapp’s MBP134, and Gilead’s Remdesivir Highlight Ongoing Efforts in Antiviral Development Regeneron’s monoclonal antibody maftivimab, Mapp Biopharmaceuticals’ MBP134, and Gilead Sciences’ remdesivir are among the therapies being prioritized …
-
Uber’s Take Rate: The Financial Disconnect Between Platform and Driver Uber’s “take rate”—the portion of a rider’s fare retained by the company—has shifted significantly over the last decade, sparking debate …
-
Amnesty International: A Global Movement for Human Rights Amnesty International is a non-governmental organization dedicated to the protection of human rights worldwide, with a global movement of more than 10 …
-
Researchers Launch Major ASPIRE Cohort Study to Address Asian American Cancer Disparities A multi-institutional research team is launching the ASPIRE Cohort, a $12.5 million study funded by the National Cancer …
-
Understanding Ozempic: Clinical Indications and Medical Context As a physician, I frequently discuss the role of semaglutide—the active ingredient in Ozempic—with patients seeking to manage complex health conditions. While recent …
-
How Strength Training Can Boost Longevity: What the Latest Research Shows Recent studies highlight the profound impact of strength training on overall health and lifespan. While aerobic exercise often takes …
-
Beyond the Brain: How Body-Wide Immune Attacks May Redefine Neurodegenerative Treatment For decades, the medical community viewed Alzheimer’s, Parkinson’s, and multiple sclerosis (MS) primarily as diseases of the central nervous …